Science & Technology
NEUMANN is a data driven company. Up to date over 7,000 cervical samples were tested in a clinical trial the company is sponsoring. This is a tremendous opportunity to show the values of NEUMANN’s CONFIDENCE™ tests. This is the largest validation study for a methylation biomarker ever conducted in the field of cervical cancer diagnostics. Numerous publications and presentations about early development results, proof-of-concept studies and the interim results are already available.